Ilya Kovalenko
AeroLeads people directory · profile

Ilya Kovalenko Email & Phone Number

CEO and Founder at Fluxion Therapeutics
Location: San Francisco, California, United States 12 work roles 2 schools
1 work email found @bio-techne.com LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email i****@bio-techne.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CEO and Founder
Location
San Francisco, California, United States

Who is Ilya Kovalenko? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Ilya Kovalenko is listed as CEO and Founder at Fluxion Therapeutics, based in San Francisco, California, United States. AeroLeads shows a work email signal at bio-techne.com and a matched LinkedIn profile for Ilya Kovalenko.

Ilya Kovalenko previously worked as Cell technology at Stealth Biostartup and Lead Biology Automation consultant at Insilico Medicine. Ilya Kovalenko holds Doctor Of Philosophy (Ph.D.), Biotechnology from Technische Universität Berlin.

Company email context

Email format at Fluxion Therapeutics

This section adds company-level context without repeating Ilya Kovalenko's masked contact details.

{first}.{last}@bio-techne.com
86% confidence

AeroLeads found 1 current-domain work email signal for Ilya Kovalenko. Compare company email patterns before reaching out.

Profile bio

About Ilya Kovalenko

Dr. Ilya Kovalenko is a TechBio professional with extensive experience in biolab automation, AI applications in automation and cell assays, preclinical drug discovery, bioassay development, along with some exposure to clinical trials.Ilya has developed bioassays and technology platforms for top companies like Bayer Healthcare, Sartorius and Insilico Medicine authoring 3 patents. His 2-years short yet efficient academic PostDoc endeavor in the University of Michigan collaboratively resulted in 10 publications.Dr Kovalenko’s interests currently are within AI applications in biolab automation, and AI-powered multidimentional bioassays for polypharmacology drug discovery. His scientific interests are within self-organizing cellular structures, electroceuticals and mitochondria.Ilya is an avid runner, a lousy surfer and global nomad (he lived in 8 countries and visited a bunch).Ilya has co-founded BioXells which aims to build an integration of Cell therapy manufacturing automation, electrophysiology and electroceuticals for a new avenue of regenerative medicines.

Listed skills include Molecular Biology, Biochemistry, Cell, Laboratory, and 47 others.

Current workplace

Ilya Kovalenko's current company

Company context helps verify the profile and gives searchers a useful next step.

Fluxion Therapeutics
Fluxion Therapeutics
CEO and Founder
San Francisco, CA, US
AeroLeads page
12 roles · 19 years

Ilya Kovalenko work experience

A career timeline built from the work history available for this profile.

Cell Technology

Current
Stealth Biostartup

We aim to build an integration of Cell therapy manufacturing automation, electrophysiology and electroceuticals for a new avenue of regenerative medicines

Feb 2024 - Present

Lead Biology Automation Consultant

Boston, Massachusetts, US

Leading massive wet lab automation project to feed PandaOMICS and Chemistry42 with consistent datasets to tackle drug discovery pipelines, aging research and many more! Leading the endeavor to build a robotic laboratory: https://bit.ly/RoboLabInsilico

Feb 2021 - May 2023

Sr. Scientist, Bioassay Development

Minneapolis, Minnesota, US

a short product pre-launch help

May 2021 - Dec 2021

Scientist

South San Francisco, California, US

Jan 2020 - Nov 2020

Sr.Scientist

Sartorius Stedim North America, Inc.

In my new role in Sartorius I am providing the leadership in novel assay development exploiting the genetic constructs and fluorescent dyes for life cell imaging applications. My new position opens me to the broad world of chemical probes for life cell imaging, 3D models, machine learning and computer vision in cell biology.Let's connect!

May 2019 - Jan 2020

Postdoctoral Fellow

Ann Arbor, MI, US

  • Developing various cell based assays to study intracellular metabolic communications in pancreatic cancer, e.g. synthetic lethality screens for metabolic pathways.
  • Developing arrayed CRISPR/Cas9 screening on heterocellular pancreatic carcinoma spheroid model. Developing High content imaging/Seahorse Metabolic Flux 96XF screening platform.
  • Identified the opportunities and established several collaborations within the University, with biotech/academic laboratories in the US and established international collaborative initiatives.
  • Multi-project responsibilities.
  • Training MS and PhD students. Managing a lab technician.
Jan 2017 - Jan 2020

Marie Curie Training Network Fellow, Phd Student

Leverkusen, North Rhine-Westphalia, DE

  • Developed Seahorse Metabolic Flux based si-RNA screening (iRNA target discovery),
  • Implemented across department exCELLignece Real-time Growth Kinetics assay for High Throughput Screening, further perfected technology in hypoxia chamber to address the group’s challenges,
  • Trained technical teams to use exCELLigence RTCA and Seahorse platforms for screening assays.
  • Participated in the development of various metabolites assays,
  • Participated in the establishment of gene signature assays for various targets.
  • Integral part of ITN IonTrak international collaboration project http://www.iontrac.uni-muenster.de/
Aug 2012 - Oct 2015

Internship

Madrid, Madrid, ES

Project “Pooled shRNA screen as a method to identify genes responsible for maintenance and self-renewal capacity of pancreatic Cancer Stem Cells”

Oct 2010 - Dec 2011

Trainee

San Diego, CA, US

  • Participated in the optimization of high-throughput cell-based assays and their scaling-up in Moscow subsidiary facility,
  • Evaluation of novel instruments for HTA in San Diego headquarters.
Aug 2007 - Sep 2009

In-House Cra

Raleigh, North Carolina, US

Phase I, IIa, IIB, III Clinical trials management, FDA and EMA regulations for oncology IND, NDA applications. Understanding the financial drivers for drug discovery initiatives.

Oct 2005 - Mar 2009
2 education records

Ilya Kovalenko education

Doctor Of Philosophy (Ph.D.), Biotechnology

Technische Universität Berlin

M.S, Biology; Cell Biology And Histology

Lomonosov Moscow State University. Biology
FAQ

Frequently asked questions about Ilya Kovalenko

Quick answers generated from the profile data available on this page.

What company does Ilya Kovalenko work for?

Ilya Kovalenko works for Fluxion Therapeutics.

What is Ilya Kovalenko's role at Fluxion Therapeutics?

Ilya Kovalenko is listed as CEO and Founder at Fluxion Therapeutics.

What is Ilya Kovalenko's email address?

AeroLeads has found 1 work email signal at @bio-techne.com for Ilya Kovalenko at Fluxion Therapeutics.

Where is Ilya Kovalenko based?

Ilya Kovalenko is based in San Francisco, California, United States while working with Fluxion Therapeutics.

What companies has Ilya Kovalenko worked for?

Ilya Kovalenko has worked for Fluxion Therapeutics, Stealth Biostartup, Insilico Medicine, Bio-Techne, and Insitro.

How can I contact Ilya Kovalenko?

You can use AeroLeads to view verified contact signals for Ilya Kovalenko at Fluxion Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Ilya Kovalenko attend?

Ilya Kovalenko holds Doctor Of Philosophy (Ph.D.), Biotechnology from Technische Universität Berlin.

What skills is Ilya Kovalenko known for?

Ilya Kovalenko is listed with skills including Molecular Biology, Biochemistry, Cell, Laboratory, Assay Development, Life Sciences, Creative Problem Solving, and Cell Culture.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.